NF-κB in allograft rejection

Hepatobiliary and Pancreatic Diseases International

Volumn 2, Issue 2, 2003, Pages 180-183

  Wei, Jian Feng ^a   Zheng, Shu Sen ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Allograft rejection; NF B

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; CORTICOSTEROID; CYCLOSPORIN; CYTOKINE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OLIGONUCLEOTIDE; SALAZOSULFAPYRIDINE; TRANSCRIPTION FACTOR;

ALLOGRAFT; DRUG TARGETING; GENE CONTROL; GENE EXPRESSION; GRAFT REJECTION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIDE EFFECT; TRANSPLANTATION;

ANIMALS; GRAFT REJECTION; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; NF-KAPPA B; TRANSPLANTATION, HOMOLOGOUS;

EID: 0038205580     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequence. Cell 1986;80:321-330.
2. Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol 2002;2:925-934.
3. Karin M, Lin A. NF-kappaB at the cross roads of life and death. Nat Immunol 2002;3:221-227.
4. Baeuerle PA, Baltimere D. NF-κB: Ten years after. Cell 1996;87:13-20.
5. Lopez FO, Suzuki Y, Sanjuan G, et al. Nuclear factor-kappa B inhibitors as potential novel anti-inflammatory agents for the treatment of immune glomerulonephritis. Am J Pathol. 2002;161:1497-1505.
6. Ghosh S, May M, Kopp E. NF-κB and Rel proteins: evolutionarily conserved mediators of the immune response. Ann Rev Immunol 1998;16:225-260.
7. Thanos D, Maniatis T. NF-κB: a lesson in family values. Cell 1995;80:529-532.
8. Ben-Neriah Y. Regulatory functions of ubiquitination in the immune system. Nat Immunol 2002;3:20-26.
9. Barnes PJ, Karin M. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N Eng J Med 1997;336:1066-1071.
10. May MJ, Sankar G. Signal transduction through NF-κB. Immunol Today 1998;19:80-88.
11. Solez K, Racusen LC, Abdulkareem F, et al. Adhesion molecules and rejection of renal allograft. Kidney Int 1997;51:1476-1480.
12. Feeley BT, Miniati DN, Park AK, et al. Nuclear factor-kappaB transcription factor decoy treatment inhibits graft coronary artery disease after cardiac transplantation in rodents. Transplantation 2000;70:1560-1568.
13. Vos IH, Govers R, Grone HJ, et al. NF-kappaB decoy oligodexynucleotides reduce monocyte infiltration in renal allografts. FASEB J 2000;14:815-822.
14. Brand K, Page S, Walli AK, et al. Role of nuclear factor-κB in atherogenesis. Exp Physiol 1997;82:297-304.
15. Janssen-Heininger YM, Poynter ME, Baeuerle PA. Recent advances towards understanding redox mechanisms in the activation of nuclear factor-kappa B. Free Radic Biol Med 2000;28:1317-1327.
16. Haddad JJ. Redox regulation of pro-inflammatory cytokines and IkappaB-alpha/NF-kappaB nuclear translocation and activation. Biochem Biophy Res Commun 2002;296:847-856.
17. Russell ME, Wallace AF, Hancock W, et al. Up-regulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection. Transplantation 1995;59: 572-578.
18. Sakurai H, Hisada Y, Ueno M, et al. Activation of transcription factor NF-kappa B in experimental glomerulonephritis in rats. Biochim. Biophys Acta 1996; 1316:132-138.
19. Azuma H, Tomita N, Kaneda Y, et al. Transfection of NF-κB-decoy oligodeoxynucleotides using efficient ultrasound mediated gene transfer into donor kidneys prolonged survival of rat renal allografts. Gene Ther 2003;10:415-425.
20. Alcalde G, Merino J, Sanz S, et al. Circulating adhesion molecules during kidney allograft rejection. Transplantation 1995;59:1695-1699.
21. Albert S, Baldwin Jr. Series introduction: the transcription factor NF-κB and human disease. J Clin Invest 2001;107:1024.
22. Meldrum DR. Tumor necrosis factor in the heart. Am J Physiol 1998;274:R577-R595.
23. Finn PW, Stone JR, Boothby MR, et al. Inhibition of NF-kappaB-dependent T cell activation abrogates acute allograft rejection. J Immunol. 2001:167:245-252.
24. Thomson AW, Lu L. Dendritic cells as regulators of immune reactivity: implications for transplantation. Transplantation 1999;68:1-8.
25. Lu L, Mc Caslin D, Starzl TE, et al. Bone marrow-derived dendritic cell progenitors induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation 1995;60:1539-1545.
26. Lu L, Bonham CA, Chambers FG, et al. Induction of nitric oxide synthase in mouse dendritic cells by IFN-gamma, endotoxin, and interaction with allogeneic T cells: Nitric oxide production is associated with dendritic cell apoptosis. J Immunol 1996;157:3577-3586.
27. Rescigno M, Martino M, Sutherland CL, et al. Dendritic cell survival and maturation are regulated by different signaling pathways. J Exp Med 1998;188:2175-2180.
28. Lu L, Thomson AW. Manipulation of dendritic cells for tolerance induction in transplantation and autoimmune disease. Transplantation 2002;73:S19-22.
29. Potoka DA, Nadler EP, Zhou X, et al. Inhibition of NF-kappaB by IkappaB prevents cytokine-induced NO production and promotes enterocyte apoptosis in vitro. Shock 2000;14:366-373.
30. Lee JI, Ganster RW, Geller DA, et al. Cyclosporine A inhibits the expression of costimulatory molecules on in vitro generated dendritic cells: association with reduced nuclear translocation of nuclear factor-kappa B. Transplantation 1999;68:1255-1263.
31. Giannoukakis N, Bonham A, Qian SG, et al. Prolongation of cardiac allograft survival using dendritic cells treated with NF-κB decoy oligodeoxyribonucleotides. Molecular Therapy 2000;1:430-437.
32. Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. J Clin Invest 2001;107:135-142.
33. Sheri MF, Jeffrey SC, Laura SG, et al. A D-amino acid peptide inhibitor of NF-κB nuclear localization if efficacious in, odels of inflammatory disease. J Immunol 2000;165:10004-10012.
34. Verma IM, Stevenson JK, Schwarz EM, et al. Genes Dev 1995;9:2723-2735.
35. Okada M, Okamoto T, Yamada S, et al. Successful treatment of chronic graft-versus-host disease with sulfasalazine in allogeneic bone marrow transplantation. Acta Haematol 1999;102:107-109.
36. Ingrid HC Vos, Roland G, Hermann J, et al. NF-κB decoy oligodeoxynucleotides reduce monocyte infiltration in renal allografts. FASEB J 2000;14:815-822.
37. Morishita R, Sugimoto T, Aoki M, et al. In vivo transfection of cis element 'decoy' against nuclear factor-Κb binding sites prevent myocardial infarction. Nat Med 1997;3:894-899.